Natco Pharma has received approval to manufacture anti-fungal drugs, while Panacea Biotec has approved production of the Russian vaccine Sputnik V.
The result of Grasim Industries has been excellent.
On Monday, the stock market closed sharply but profit booking also showed. There was buying in public sector, power, oil and utilities companies, while profit booking was seen in telecom, metal and FMCG, consumer durables companies. On Monday at 7 pm Dow Jones was seeing a spurt of 122 points. Corona cases are also decreasing. These signs are positive for the market.
Today, try to find out what the condition of the market will be and who will be in the discussion. SBI was gaining momentum on Monday. After the result, all the brokerages have upgraded the target price of its stock to 600 rupees. In such a situation, there is a possibility of a rise in its stock even today.
Natco Pharma approved to make antifungal medicine
Keep an eye on Natco Pharma’s stock today as the company has received approval from DCGI to manufacture antifungal medicine medicine. It is used in the treatment of black fungus. Its stock rose nearly 10 percent on Monday. Apart from this, Bal Pharma has launched favipiravir used in the treatment of corona.
Grasim Industries, Panacea Biotec Share In Discussion
Grasim Industries has seen a 36 per cent increase in profits and 18 per cent in revenue. Its stock closed on Monday with a slight decline. Apart from this, Panacea Biotec has approved the production of the Russian vaccine Sputnik V. On Monday, the stock had gained about 3.50 per cent. WPIL Ltd. has received a contract of 410 crores from the Government of West Bengal. The stock gained 11.20 percent on Monday.
Also read, the stock market created history, market cap crossed $ 3 trillion for the first time, doubled in just 7 years
Also read, revealed in RBI report, loan fraud of 5 lakh crores has been done with banks, maximum 78 thousand crores with SBI